Table 1.
N | M/F | Age | Type | FISH:S/H | N.Previous lines | Dara-therapy | N.Dara previous infusions | IRR1 dose | N.Rapid infusions | IRR in Rapid infusions | Disease status before Dara | Bestresponse | PD:Y/N | FUO/infection | A/D |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 68 | IgA κ | S | 3 | DVd | 16 | No | 4 | None | RR | PR | Y | Yes | Dead |
2 | M | 84 | IgG κ | S | 6 | DRd | 3 | No | 28 | None | RR | PR | N | Yes | Alive |
3 | M | 57 | IgG κ | ND | 4 | DVd | 5 | No | 18 | None | RR | PR | N | Yes | Alive |
4 | M | 60 | BJ.κ | H | 6 | DRd | 3 | No | 24 | None | RR | PR | Y | Yes | Dead |
5 | M | 53 | IgG κ | H | 2 | DPd | 2 | Yes | 12 | None | RR | SD | Y | Yes | Dead |
6 | M | 71 | IgG κ | N | 1 | DRd | 2 | No | 21 | None | RR | CR | N | No | Alive |
7 | M | 58 | BJ.λ | S | 1 | DRd | 2 | Yes | 19 | None | RR | PR | N | Yes | Alive |
8 | F | 62 | IgG λ | N | 6 | Dara alone | 13 | No | 1 | None | RR | PR | Y | Yes | Dead |
9 | M | 57 | IgG λ | N | 3 | DRd | 5 | Yes | 7 | None | RR | SD | Y | No | Dead |
10 | M | 65 | IgG λ | N | 1 | DRd | 2 | Yes | 4 | None | RR | VGPR | N | Yes | Alive |
11 | M | 63 | BJ λ | N | 1 | Dara alone | 2 | No | 19 | None | RR | VGPR | N | Yes | Alive |
12 | M | 63 | IgG λ | ND | 1 | Dara alone | 12 | No | 18 | None | RR | PR | N | No | Alive |
13 | M | 49 | IgG/k | H | 6 | Dara Alone | 13 | No | 4 | None | RR | PR | Y | No | Dead |
14 | F | 55 | IgG/k | H | 2 | DVd | 2 | No | 11 | None | RR | PR | N | No | Alive |
15 | F | 63 | IgG/k | S | 6 | DRd | 2 | No | 9 | None | RR | VGPR | N | No | Alive |
16 | M | 64 | BJ/λ | S | 2 | DRd | 2 | No | 7 | None | RR | VGPR | N | No | Alive |
17 | M | 45 | IgG/k | S | 1 | DRd | 2 | No | 1 | None | RR | NA | N | No | Alive |
18 | M | 61 | IgG/k | S | 4 | DVd | 2 | No | 1 | None | RR | NA | N | No | Alive |
19 | F | 63 | BJ/λ | S | 1 | DRd | 2 | Yes | 1 | None | RR | NA | N | No | Alive |
20 | F | 51 | IgG κ | S | 1 | DART4MM | 2 | No | 21 | None | CR-MRD pos | CR | N | No | Alive |
21 | F | 63 | IgG κ | S | 1 | DART4MM | 2 | No | 14 | None | CR-MRD pos | CR | N | No | Alive |
22 | M | 71 | IgA λ | S | 1 | DART4MM | 2 | No | 14 | None | VGPR | sCR-MRD neg | N | No | Alive |
23 | M | 62 | IgG k | S | 1 | DART4MM | 2 | No | 16 | None | CR-MRD pos | CR | N | No | Alive |
24 | F | 65 | IgG k | S | 1 | DART4MM | 2 | No | 16 | None | VGPR | VGPR | N | No | Alive |
25 | F | 72 | IgG λ | H | 1 | DART4MM | 3 | Yes | 26 | None | VGPR | VGPR | Y | No | Alive |
26 | F | 78 | IgG κ | N | 1 | DART4MM | 2 | Yes | 30 | None | VGPR | CR | N | No | Alive |
27 | M | 71 | IgG κ | S | 1 | DART4MM | 2 | No | 14 | None | VGPR | sCR-MRD neg | N | No | Alive |
28 | M | 66 | IgG λ | ND | 1 | DART4MM | 2 | No | 14 | None | VGPR | CR-MRD neg | N | No | Alive |
29 | F | 65 | IgG λ | S | 1 | DART4MM | 2 | Yes | 14 | None | CR-MRD pos | CR-MRD neg | N | No | Alive |
30 | M | 55 | BJ λ | ND | 1 | DART4MM | 2 | No | 14 | None | CR-MRD pos | CR-MRD neg | N | No | Alive |
31 | M | 58 | IgG κ | S | 1 | DART4MM | 2 | Yes | 14 | None | VGPR | CR-MRD neg | N | No | Alive |
32 | M | 48 | IgG λ | S | 1 | DART4MM | 2 | No | 14 | None | CR-MRD pos | CR-MRD neg | N | No | Alive |
33 | M | 70 | IgG/k | S | 1 | DART4MM | 2 | No | 18 | None | VGPR | VGPR | N | No | Alive |
34 | F | 66 | IgG/k | S | 1 | DART4MM | 2 | No | 12 | None | VGPR | CR | N | No | Alive |
35 | M | 65 | IgG/k | S | 1 | DART4MM | 2 | Yes | 15 | None | VGPR | VGPR | N | No | Alive |
36 | M | 66 | IgG k | S | 1 | DART4MM | 2 | No | 5 | None | VGPR | NA | N | No | Alive |
37 | M | 62 | IgG/k | S | 1 | DART4MM | 2 | Yes | 2 | None | CR-MRD pos | NA | N | No | Alive |
38 | M | 52 | IgG/k | S | 1 | DART4MM | 2 | Yes | 1 | None | VGPR | NA | N | No | Alive |
39 | F | 59 | IgG/k | S | 1 | DART4MM | 2 | Yes | 1 | None | VGPR | NA | N | No | Alive |
FISH : ND, not done; H = high risk (t 4;14-t14;16-del 17p); S, standard risk (all other anomalies); N, normal; DVd, dara, velcade, dexamethasone; DRd, Dara, Revlimid, dexamethasone; DPd, Dara, Pomalidomide, dexamethasone; NA, not applicable (too early for assessment); IRR, infusion-related reaction; FUO, fever of unknown origin.
N Rapid infusions and IRRR in Rapid infusions columns are evidenced in bold.